200 studies found for:    Open Studies | "Protozoan Infections"
Show Display Options
Rank Status Study
1 Unknown  Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158
Conditions: Trypanosomiasis;   Trypanosomiasis, African;   Protozoan Infections;   Parasitic Diseases
Interventions: Drug: SCYX-7158;   Drug: Placebo
2 Not yet recruiting Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya
Conditions: Cryptosporidium;   Cryptosporidiosis;   Waterborne Disease;   Diarrheal Disease
Intervention: Other: Ceramic water filter
3 Recruiting Parasitic Infections of the Gastrointestinal Tract
Conditions: Amebiasis;   Cryptosporidiosis;   Giardiasis;   Parasitic Disease;   Parasitic Intestinal Disease;   Gastrointestinal Helminth Infections
Intervention:
4 Unknown  Babesia Testing in Blood Donors
Condition: Transfusion Transmitted Babesiosis
Intervention: Biological: B.microti diagnostic blood tests
5 Recruiting Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events
Conditions: HIV;   Malnutrition;   Cryptosporidiosis
Intervention:
6 Recruiting Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy
Condition: Congenital Toxoplasmosis
Interventions: Drug: Pyrimethamine/Sulfadiazine;   Drug: Spiramycine
7 Recruiting Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide as Adjunctive Treatment for Cerebral Malaria in Children
Condition: Cerebral Malaria
Interventions: Drug: inhaled nitric oxide;   Drug: Placebo
8 Recruiting A Dose-Escalation, Safety and Feasibility Study of Enteral Levetiracetam for Seizure Control in Pediatric Cerebral Malaria
Conditions: Seizure;   Epilepsy;   Cerebral Malaria
Interventions: Drug: Oral Levetiracetam;   Drug: Standard AED
9 Recruiting Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis
Condition: Congenital Toxoplasmosis
Interventions: Procedure: reducing treatment to 3 months;   Procedure: registered length of treatment
10 Recruiting Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Condition: Toxoplasmosis
Interventions: Drug: Leucovorin calcium;   Drug: Pyrimethamine;   Drug: Spiramycin;   Drug: Sulfadiazine
11 Unknown  Randomized Trial of Erythropoietin During Cerebral Malaria
Condition: Cerebral Malaria
Interventions: Drug: Placebo;   Drug: Erythropoietin
12 Available Expanded Access WR 279396 Topical Cream Treatment for Uncomplicated Cutaneous Leishmaniasis
Condition: Leishmaniasis, Cutaneous
Intervention: Drug: WR 279,396
13 Unknown  Pilot Study Using a Heat Pack to Treat Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Intervention: Device: Heat pack conduction-heat therapy
14 Recruiting Adherence to Antimalarial Drugs in Sierra Leone
Condition: Malaria
Interventions: Drug: amodiaquine-artesunate (AQAS) co-formulated;   Drug: Artemether-lumefantrine combination (AL)
15 Unknown  Human Immunity to MSP-1 in Western Kenya
Condition: Plasmodium Falciparum Malaria
Intervention:
16 Not yet recruiting Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail Sector
Conditions: Fever;   Malaria
Interventions: Other: Free Malaria Rapid Diagnostic Test;   Other: Conditional ACT voucher;   Other: Malaria Rapid Diagnostic test for a charge
17 Recruiting New Tools for the Diagnosis, Prognosis and Treatment Follow-up in Chagas Disease
Condition: Chagas Disease
Intervention: Drug: Benznidazole
18 Unknown  Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular Toxoplasmosis
Condition: Ocular Toxoplasmosis
Intervention: Drug: Trimethoprim-Sulfamethoxazole
19 Recruiting A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of New Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 RH5 Alone and With MVA RH5
Conditions: Malaria;   Plasmodium Falciparum
Interventions: Biological: ChAd63 RH5 low dose;   Biological: ChAd63 RH5 full dose;   Biological: MVA RH5 low dose;   Biological: MVA RH5 full dose
20 Recruiting The Optimal Timing Of Primaquine To Prevent Malaria Transmission After Artemisinin-Combination Therapy
Condition: Malaria Transmission
Interventions: Drug: Artemether Lumefantrine;   Drug: Artemether Lumefantrine 6 dose regimen & single dose of Primaquine on day 0;   Drug: Artemether Lumefantrine 6 dose regimen and single dose Primaquine on day 2

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years